Tobacco use prevalence, knowledge, and attitudes among newly diagnosed tuberculosis patients in Penang State and Wilayah Persekutuan Kuala Lumpur, Malaysia
More details
Hide details
Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia, Kuantan, Malaysia
Department of Health Economics & Finance, Institute for Health Management, NIH, Ministry of Health, Kuala Lumpur, Malaysia
Department of Respiratory Medicine, Penang Hospital, Jalan Residensi, Penang, Malaysia
Institut Perubatan Respiratori, Kuala Lumpur, Malaysia
Ahmed Awaisu   

Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia
Publish date: 2010-01-12
Tobacco Induced Diseases 2010;8(January):3
There is sufficient evidence to conclude that tobacco smoking is strongly linked to tuberculosis (TB) and a large proportion of TB patients may be active smokers. In addition, a previous analysis has suggested that a considerable proportion of the global burden of TB may be attributable to smoking. However, there is paucity of information on the prevalence of tobacco smoking among TB patients in Malaysia. Moreover, the tobacco-related knowledge, attitudes, and behaviors of TB patients who are smokers have not been previously explored. This study aimed to document the prevalence of smoking among newly diagnosed TB patients and to learn about the tobacco use knowledge and attitudes of those who are smokers among this population.

Data were generated on prevalence rates of smoking among newly diagnosed TB patients in the State of Penang from January 2008 to December 2008. The data were obtained based on a review of routinely collated data from the quarterly report on TB case registration. The study setting comprised of five healthcare facilities (TB clinics) located within Penang and Wilayah Persekutuan, Kuala Lumpur health districts in Malaysia, which were involved in a larger project, known as SCIDOTS Project. A 58-item questionnaire was used to assess the tobacco use knowledge, attitudes and behaviors of those TB patients who were smokers.

Smoking status was determinant in 817 of 943 new cases of TB from January to December 2008. Of this, it was estimated that the prevalence rates of current- and ex-smoking among the TB patients were 40.27% (329/817) and 13.95% (114/817), respectively. The prevalence of ever-smoking among patients with TB was estimated to be 54,220 per 100,000 population. Of 120 eligible participants for the SCIDOTS Project, 88 responded to the survey (73.3% response rate) and 80 surveys were analyzed (66.7% usable rate). The mean (± SD) total score of tobacco use knowledge items was 4.23 ± 2.66 (maximum possible score=11). More than half of the participants (51.3%) were moderately dependent to nicotine. A moderately large proportion of the respondents (41.2%) reported that they have ever attempted to quit smoking, while more than half (56.3%) have not. Less than half (47.5%) of the study participants had knowledge about the body system on which cigarette smoking has the greatest negative effect. The majority wrongly believed that smokeless tobacco can increase athletic performance (60%) and that it is a safe and harmless product (46.2%). An overwhelming proportion (>80%) of the patients believed that: smoking is a waste of money, tobacco use is very dangerous to health, and that smokers are more likely to die from heart disease when compared with non-smokers. The use of smokeless tobacco was moderately prevalent among the participants with 28.8% reporting ever snuffed, but the use of cigar and pipe was uncommon.

Smoking prevalence rate is high among patients with TB in Malaysia. These patients generally had deficiencies in knowledge of tobacco use and its health dangers, but had positive attitudes against tobacco use. Efforts should be geared towards reducing tobacco use among this population due to its negative impact on TB treatment outcomes.

Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher DJ, Sharma SK: Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther. 2007, 5 (3): 385-391. 10.1586/14787210.5.3.385.
WHO: WHO report on the global tobacco epidemic. 2008, Geneva, Switzerland: WHO, 1-329.
WHO: WHO report on the global tuberculosis control. 2008, Geneva, Switzerland WHO, 1.
Lin HH, Ezzati M, Murray M: Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med. 2007, 4 (1): e20-10.1371/journal.pmed.0040020.
Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007, 167 (4): 335-342. 10.1001/archinte.167.4.335.
Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, Ray C: Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007, 11 (10): 1049-1061.
Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, Rook GA: Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg. 2006, 100 (4): 291-298. 10.1016/j.trstmh.2005.06.034.
d'Arc Lyra Batista J, de Fatima Pessoa Militao de Albuquerque M, de Alencar Ximenes RA, Rodrigues LC: Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol. 2008, 37 (4): 841-851.
Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Selvakumar N, Ganapathy S, Charles N, Rajamma J: Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis. 2002, 6 (9): 780-788.
Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, Eusuff SI, Sadacharam K, Narayanan PR: Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis. 2005, 9 (5): 556-561.
Chang KC, Leung CC, Tam CM: Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis. 2004, 8 (12): 1492-1498.
Gajalakshmi V, Peto R, Kanaka TS, Jha P: Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet. 2003, 362 (9383): 507-515. 10.1016/S0140-6736(03)14109-8.
WHO: Tobacco or health: A global status report. 1997, Geneva: WHO.
Zellweger JP: Tobacco and tuberculosis. Monaldi Arch Chest Dis. 2008, 69 (2): 83-85.
Lienhardt C, Fielding K, Sillah JS, Bah B, Gustafson P, Warndorff D, Palayew M, Lisse I, Donkor S, Diallo S: Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol. 2005, 34 (4): 914-923. 10.1093/ije/dyi100.
Schneider NK, Novotny TE: Addressing smoking cessation in tuberculosis control. Bull World Health Organ. 2007, 85 (10): 820-821. 10.2471/BLT.07.034797.
Yach D: Partnering for better lung health: improving tobacco and tuberculosis control. Int J Tuberc Lung Dis. 2000, 4 (8): 693-697.
Wang J, Shen H: Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health. 2009, 9: 292-10.1186/1471-2458-9-292.
Siddiqi K, Lee AC: An integrated approach to treat tobacco addiction in countries with high tuberculosis incidence. Trop Med Int Health. 2009, 14 (4): 420-428. 10.1111/j.1365-3156.2009.02238.x.
Torabi MR, Yang J, Li J: Comparison of tobacco use knowledge, attitude and practice among college students in China and the United States. Health Promot Int. 2002, 17 (3): 247-253. 10.1093/heapro/17.3.247.
Meier KS: Tobacco truths: the impact of role models on children's attitudes toward smoking. Health Educ Q. 1991, 18 (2): 173-182.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991, 86 (9): 1119-1127. 10.1111/j.1360-0443.1991.tb01879.x.
DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991, 59 (2): 295-304. 10.1037/0022-006X.59.2.295.
Pradeepkumar AS, Thankappan KR, Nichter M: Smoking among tuberculosis patients in Kerala, India: proactive cessation efforts are urgently needed. Int J Tuberc Lung Dis. 2008, 12 (10): 1139-1145.
Altet-Gomez MN, Alcaide J, Godoy P, Romero MA, Hernandez del Rey I: Clinical and epidemiological aspects of smoking and tuberculosis: a study of 13,038 cases. Int J Tuberc Lung Dis. 2005, 9 (4): 430-436.
Ng N, Padmawati RS, Prabandari YS, Nichter M: Smoking behavior among former tuberculosis patients in Indonesia: intervention is needed. Int J Tuberc Lung Dis. 2008, 12 (5): 567-572.
Ministry of Health Malaysia: Report of the Third National Health and Morbidity Survey. 2006, Public Health Institute, Minstry of Health Malaysia.
Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M: The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009, 11 (1): 12-24. 10.1093/ntr/ntn010.
Outcomes of tuberculosis treatment: a retrospective cohort analysis of smoking versus non-smoking patients in Penang, Malaysia
Juman Abdulelah Dujaili, Syed Azhar Syed Sulaiman, Ahmed Awaisu, Abdul Razak Muttalif, Ali Qais Blebil
Journal of Public Health
The SCIDOTS Project: Evidence of benefits of an integrated tobacco cessation intervention in tuberculosis care on treatment outcomes
Ahmed Awaisu, Mohamad Haniki Nik Mohamed, Noorliza Mohamad Noordin, Noorizan Abd Aziz, Syed Azhar Syed Sulaiman, Abdul Razak Muttalif, Aziah Ahmad Mahayiddin
Substance Abuse Treatment, Prevention, and Policy
Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control
Bruce J Kirenga, Willy Ssengooba, Catherine Muwonge, Lydia Nakiyingi, Stephen Kyaligonza, Samuel Kasozi, Frank Mugabe, Martin Boeree, Moses Joloba, Alphonse Okwera
BMC Public Health
Tobacco use patterns in tuberculosis patients with high rates of human immunodeficiency virus co-infection in South Africa
Goedele MC Louwagie, Olalekan A Ayo-Yusuf
BMC Public Health
Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life
Ahmed Awaisu, Mohamad Haniki Nik Mohamed, Noorliza Noordin, Abdul Muttalif, Noorizan Aziz, Syed Syed Sulaiman, Aziah Mahayiddin
Tobacco Induced Diseases
Barriers to Smoking Cessation Among Drug-Resistant Tuberculosis Patients in South Africa
Zifikile Phindile Shangase, Joyce Mahlako Tsoka-Gwegweni, Catherine O. Egbe
Annals of Global Health
Impact of additional counselling sessions through phone calls on smoking cessation outcomes among smokers in Penang State, Malaysia
Ali Qais Blebil, Syed Azhar Syed Sulaiman, Mohamed Azmi Hassali, Juman Abdulelah Dujaili, Alfian Mohamed Zin
BMC Public Health
A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis
Mahshid Aryanpur, Mostafa Hosseini, Mohammad Reza Masjedi, Esmaeil Mortaz, Payam Tabarsi, Hamid Soori, Habib Emami, Gholamreza Heidari, Mehdi Kazempour Dizagie, Masoud Baikpour
BMC Infectious Diseases
Specchio Riflesso. Un intervento multidimensionale di prevenzione primaria del tabagismo nella preadolescenza
Dario Monzani, Marco D’Addario, Alessio Gamba, Daniela Giangreco, Luca De Lucia, Alice Bescapè, Antonella Imperatori-Gelosa, Michela Oleotti, Marco Alloisio, Patrizia Steca
The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis
Y. Ma, N.-Y. Che, Y.-H. Liu, W. Shu, J. Du, S.-H. Xie, Liang Li
European Journal of Clinical Microbiology & Infectious Diseases